Bionow | News

T2510/18 – Exceptions to Patentability and Novelty of Naturally Occurring Subs...

Oct 23rd 2024

The European Patent Office’s recent decision T2510/18 offers valuable insights into the patentability of naturally occurring substances. The ruling clarifies that the exception to patentab...

An update on the patentability of antibodies at the European Patent Office

Mar 16th 2024

The EPO has recently issued updated Guidelines for Examination, which entered into force on 1 March 2024. Some of the most significant modifications have been made to the guidance surroundin...

Why AI-Generated Patent Applications Can Put Your Innovation at Risk

Jan 12th 2024

Tools like ChatGPT and Bard promise to simplify the patent process, slashing costs and saving time. However, when it comes to safeguarding your intellectual property, these AI assistants can...

Boost Startup Success with IP Rights: New Study Reveals Insights

Nov 7th 2023

A new study from the European Patent Office and the EU Intellectual Property Office has shed light on the undeniable advantages of IP rights for startups.

Protecting Smart Health Wearable Innovations with Intellectual Property

Oct 26th 2023

The smart health wearables market in Europe is booming, and intellectual property protection is essential for success. Discover the keys to safeguarding your IP in our latest article, where ...

Medtech sector sees surge in AI patent applications

Sep 26th 2023

Marks & Clerk AI Report 2023 reveals an interesting insight into the latest trends in patent applications

A cure for resistance? How ultra-long patent terms may entice pharma to address...

Jan 6th 2023

Addressing the antimicrobial resistance crisis will require a multifaceted approach - could extending patent terms encourage pharmaceutical companies to drive innovation in this area? Potte...

Eating protein from lab-grown, plant and insect sources takes giant steps to wid...

Dec 7th 2022

Inside Green Innovation: Progress Report 2022, from leading intellectual property firm Appleyard Lees’, analyses patent filings across several key environmental issues facing the world, in...

N-Site Video Launch

Jun 17th 2021

We’re pleased to announce the launch of our N-Site Video which covers who we are, what we do and how we can offer guidance to Life Sciences companies.

Medtech innovation is going digital but is patent protection keeping up?

Apr 22nd 2021

The medtech sector has remained at the forefront of innovation during the pandemic with a multitude of new technologies being developed to help tackle the coronavirus crisis

AI in the pharmaceutical industry

Mar 2nd 2021

Why aren’t the major pharmaceutical companies filing patents to AI-related inventions?

Neoantigens: IP considerations for an emerging class of cancer immunotherapy

Sep 16th 2020

Recent cell and gene therapy product approvals have allowed the pharmaceutical industry to start a new age of innovation regarding cancer treatment, moving away from the more homogeneous the...

News